Ezekowitz Alan
- SEC CIK
- 0001780209
In the past year, 1 open-market sale filing worth $65.7K and no purchases.
Current role at each company
- FULC Fulcrum Therapeutics, Inc.Directoras of Jul 2, 2026
- SEPN Septerna, Inc.Directoras of Jun 30, 2026
- OGN Organon & Co.Directoras of Jun 15, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $65.7K
- 1 filing
- Net
- −$65.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Ezekowitz Alan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FULC Fulcrum Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 (view filing) | Jun 26 | 4 days | Ezekowitz AlanDirector | SSale | −18.0K | $3.65 | −$65.7K | −62.2%10.9K after |
SEPN Septerna, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 (view filing) | Mar 7 | 3 days | Ezekowitz AlanDirector | PPurchase | +13.3K | $6.93 | +$92.3K | +12.8%117.4K after | |
| Mar 6, 2025 (view filing) | Mar 4-6 | 2 days | Ezekowitz AlanDirector | PPurchase | +86.7K | $5.95 | +$515.9K | +497.6%104.1K after | 3 lots |